Differentiation of 3-O-sulfated heparin disaccharide isomers: identification of structural aspects of the heparin CCL2 binding motif.
about
Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometryHeparan sulfate 3-O-sulfation: a rare modification in search of a function.A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycansStructurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycansMethod development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes.Recent progress and applications in glycosaminoglycan and heparin research.Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.High-field asymmetric-waveform ion mobility spectrometry and electron detachment dissociation of isobaric mixtures of glycosaminoglycansAnalysis of Glycosaminoglycans Using Mass Spectrometry.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.ESI-MS differential fragmentation of positional isomers of sulfated oligosaccharides derived from carrageenans and agarans.Glycosaminoglycan Analysis by Cryogenic Messenger-Tagging IR Spectroscopy Combined with IMS-MS.
P2860
Q33546538-571EFC46-2BA0-4AE7-89C0-4DE572EA4D6EQ33690545-D7F9C3BD-DDE8-4D16-AD86-680A20ABCC7AQ34981189-B618633D-9B0F-4182-B717-6CA93F83D7F4Q35763876-4C510894-AEFF-411B-8271-2FBD0528FBFFQ36742437-D7557C75-CBEB-4CB4-B908-551761899EE2Q37089817-D23C3F86-CAD1-4BBC-9D2D-8CAFCF1B0A32Q37455553-16442576-53B0-416F-A9EC-5782551599CCQ37469129-5E5464C6-72C7-4520-ADC6-D41A142BB0C7Q37625343-AED3407C-BAB3-4C95-B497-9EF9BB279AD1Q38338415-1DF40594-7AED-4950-AB9D-3D6FC20B5803Q38418286-8A9D8112-AC66-4FD8-A33F-76788250FFDFQ42169559-D2E32E26-7476-4C56-809F-CF28AE8673F9Q48244850-82932DCB-6E95-4BAC-9535-639256E88699
P2860
Differentiation of 3-O-sulfated heparin disaccharide isomers: identification of structural aspects of the heparin CCL2 binding motif.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@en
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@nl
type
label
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@en
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@nl
prefLabel
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@en
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@nl
P2093
P2860
P1476
Differentiation of 3-O-sulfate ...... he heparin CCL2 binding motif.
@en
P2093
Jeffrey D Esko
John K Meissen
Julie A Leary
Matthew D Sweeney
Matthew Girardi
Roger Lawrence
P2860
P2888
P304
P356
10.1016/J.JASMS.2008.12.002
P577
2008-12-09T00:00:00Z
P5875
P6179
1034055307